V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194776 | 20152161 | 1.88 | 62.1 | Palliative (P) | 2020-12-01 | 2020-12-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101311318 |
| 20194795 | 20152162 | 1.83 | 62.6 | Adjuvant (A) | 2020-03-12 | 2020-03-21 | Docetaxel 75mg/m2 (21 day) | 99 | N | DOCETAXEL | 100626954 |
| 20194797 | 20152163 | 1.81 | 109.2 | Neo-adjuvant (N) | 2019-01-21 | 2019-01-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101699241 |
| 20194798 | 20152164 | 1.63 | 50.2 | Palliative (P) | 2017-11-25 | 2017-11-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101680961 |
| 20194799 | 20152165 | 1.75 | 89 | Palliative (P) | 2017-01-16 | 2017-01-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100394281 |
| 20194802 | 20152166 | 0 | 70.5 | null | 2017-10-24 | 2017-11-08 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101463136 |
| 20194806 | 20152167 | 1.66 | 77.7 | Palliative (P) | 2018-04-23 | 2018-05-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101048215 |
| 20194812 | 20152168 | 1.74 | 70 | Palliative (P) | 2016-04-05 | 2016-04-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100480825 |
| 20194838 | 20152169 | 1.61 | 55.6 | Palliative (P) | 2017-03-08 | 2018-03-17 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100796157 |
| 20194839 | 20152170 | 1.76 | 86 | Palliative (P) | 2020-01-17 | 2021-01-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100997796 |
| 20194840 | 20152171 | 1.84 | 58.2 | null | 2019-05-18 | 2019-05-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100683428 |
| 20194852 | 20152172 | 1.76 | 60 | Adjuvant (A) | 2016-06-11 | 2016-06-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100758971 |
| 20194871 | 20152173 | 1.66 | 50.6 | Palliative (P) | 2018-02-03 | 2018-02-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100805802 |
| 20194876 | 20152174 | 1.7 | 88 | null | 2016-08-10 | 2016-12-04 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101842617 |
| 20194909 | 20152175 | 1.59 | 110.9 | Palliative (P) | 2020-04-30 | 2021-09-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100170534 |
| 20194915 | 20152176 | 1.73 | 59 | Palliative (P) | 2019-11-11 | 2019-11-18 | Docetaxel | 02 | N | DOCETAXEL | 100514606 |
| 20194918 | 20152177 | 1.69 | 40 | Palliative (P) | 2016-12-19 | 2016-12-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100948621 |
| 20194938 | 20152178 | 1.88 | 66.8 | Palliative (P) | 2017-06-19 | 2017-07-01 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101360944 |
| 20194939 | 20152179 | 1.67 | 80 | Adjuvant (A) | 2016-08-13 | 2016-08-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100254507 |
| 20194941 | 20152180 | 1.56 | 74.5 | Neo-adjuvant (N) | 2021-05-24 | 2021-05-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101319888 |
| 20194949 | 20152181 | 1.74 | 83 | Curative (C) | 2017-03-26 | 2017-04-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100170013 |
| 20194952 | 20152182 | 1.36 | 53 | null | 2019-10-30 | 2020-06-18 | Docetaxel | 02 | null | DOCETAXEL | 101521244 |
| 20194953 | 20152183 | 1.7 | 59.3 | Adjuvant (A) | 2017-04-21 | 2017-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100308673 |
| 20194955 | 20152184 | 1.59 | 70 | Palliative (P) | 2016-03-04 | 2016-09-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101456109 |
| 20194958 | 20152185 | 1.81 | 51.8 | null | 2017-10-04 | 2017-10-14 | Docetaxel 75mg/m2 (21 day) | N | null | DOCETAXEL | 101713535 |
| 20194962 | 20152186 | 1.77 | 78 | Palliative (P) | null | 2016-08-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100975549 |
| 20194964 | 20152187 | 1.75 | 89 | null | 2020-05-03 | 2020-05-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101267483 |
| 20194965 | 20152188 | 1.76 | 82.6 | Palliative (P) | 2019-10-15 | 2019-10-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101299289 |
| 20194975 | 20152189 | 1.62 | 95 | null | 2022-02-06 | 2022-02-06 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100210279 |
| 20194977 | 20152190 | 1.74 | 115.9 | Palliative (P) | 2016-06-07 | 2016-06-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101228183 |
| 20194989 | 20152191 | 1.8 | 70.1 | Palliative (P) | null | 2020-04-20 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100734493 |
| 20194993 | 20152192 | 1.59 | 65.4 | null | 2021-10-24 | 2021-10-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101427435 |
| 20194999 | 20152193 | 1.81 | 98 | Palliative (P) | 2016-12-18 | 2016-12-24 | Docetaxel | 02 | N | DOCETAXEL | 101606783 |
| 20195021 | 20152194 | 1.83 | 49.7 | Palliative (P) | 2017-06-17 | 2017-06-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100280301 |
| 20195024 | 20152195 | 1.73 | 56.5 | Palliative (P) | 2017-12-07 | 2017-12-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100506585 |
| 20195031 | 20152196 | 1.8 | 108 | null | 2020-03-30 | 2020-04-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100593671 |
| 20195038 | 20152197 | 1.63 | 84.4 | null | null | 2020-08-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101207605 |
| 20195072 | 20152198 | 1.41 | 72 | null | 2020-02-22 | 2020-03-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100163812 |
| 20195082 | 20152199 | null | 56.1 | Palliative (P) | 2019-08-16 | 2021-02-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101819017 |
| 20195085 | 20152200 | 1.59 | 46.4 | Adjuvant (A) | 2019-05-01 | 2019-05-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101406283 |
| 20195089 | 20152201 | 1.83 | 46.3 | Palliative (P) | 2017-03-03 | 2017-03-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101735188 |
| 20195090 | 20152202 | 1.85 | 54 | Palliative (P) | 2017-02-22 | 2017-03-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101022150 |
| 20195101 | 20152203 | 1.66 | 58.3 | Palliative (P) | null | 2019-03-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100639655 |
| 20195102 | 20152204 | 1.62 | 93.6 | null | 2018-03-21 | 2018-03-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101264500 |
| 20195110 | 20152205 | 1.67 | 86.4 | Palliative (P) | null | 2018-06-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100776215 |
| 20195111 | 20152206 | 1.63 | 139 | null | 2016-10-24 | 2017-05-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101391939 |
| 20195127 | 20152207 | 1.67 | 67.85 | Palliative (P) | 2019-08-01 | 2019-08-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100337188 |
| 20195130 | 20152208 | 1.68 | 61 | Palliative (P) | 2015-06-07 | 2017-03-30 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101001263 |
| 20195137 | 20152209 | 1.53 | 46.4 | Palliative (P) | 2018-11-09 | 2018-11-22 | Docetaxel | 02 | N | DOCETAXEL | 100044938 |
| 20195145 | 20152210 | 1.59 | 96.2 | Palliative (P) | 2017-12-20 | 2018-01-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100528602 |